DIALYSIS · CCN 552779
DaVita El Sobrante Dialysis
SAN PABLO, CA 94803
DialysisProfitDaVita
$6.6M
TOTAL REVENUE
33.5%
OPERATING MARGIN
4 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL
Cost report financials (FY2025)
- Net patient revenue
- $6.6M
- Total costs
- $4.4M
- Operating income (rev − costs)
- $2.2M
- Operating margin
- 33.5%
- Total charges
- $6.6M
- Total treatments
- 14,297
- Dialysis stations
- 20
Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.
02 — QUALITY MEASURES
12 quality measures
| Measure | Score | Denominator | Period |
|---|---|---|---|
Standardized ED Visits Within 30 Days of Hospital Discharge DFC_ED30 | 1.92 | 46 | — |
Fistula Rate DFC_FISTULA_RATE | 57.1 | 116 | — |
Five Star Rating DFC_FIVE_STAR | 4 | — | — |
First Year Standardized Kidney Transplant Waitlist Ratio DFC_FYSWR | 1.29 | 27 | — |
Healthcare Worker COVID-19 Vaccination Adherence DFC_HCP_VACC | 0 | — | — |
Patient Hospitalization Rate DFC_HOSPITALIZATION_RATE | 95.2 | 87 | — |
Standard Infection Ratio (SIR) DFC_INFECTION_RATIO | 0.13 | — | — |
Percentage of Adult Patients with Long Term Catheter in Use DFC_LONG_CATHETER | 21 | 116 | — |
Patient Survival (Mortality Rate) DFC_MORTALITY_RATE | 18.7 | 399 | — |
Percentage of Prevalent Patients Waitlisted for Kidney Transplant DFC_PPPW | 36.9 | 85 | — |
Patient Hospital Readmission Rate DFC_READMISSION_RATE | 27.5 | 61 | — |
Standardized ED Visits Ratio DFC_SEDR | 0.96 | 18 | — |